Fund has awarded a $4.5m grant to US-based diagnostic developer Fluxus, a Fujirebio subsidiary, to develop an ultrasensitive ...

THIRUVANANTHAPURAM: The state health department has mapped 81.6 lakh individuals at high risk of tuberculosis (TB) as it ...

The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be ...

A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

A point-of-care lung ultrasound system connected to a smartphone combined with a suite of deep learning models outperformed ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).

Findings presented at ESCMID Global 2025 highlight the potential of AI-enhanced ultrasound as a frontline diagnostic tool for ...

A study has shown that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis ...

A pioneering study presented today at ESCMID Global 2025 has demonstrated that an AI-powered lung ultrasound outperforms human experts by 9% in diagnosing pulmonary tuberculosis (TB).1 ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

and improve outcomes for patients with drug-resistant TB. More information: Medha Singh et al, Proapoptotic Bcl-2 inhibitor as potential host directed therapy for pulmonary tuberculosis ...